Table 1 of Nassiri, Mol Vis 2012; 18:1991-1995.
Control | Glaucoma | |||||
---|---|---|---|---|---|---|
Variables | Senile cataract | POAG | PXFG | NVG | Total | p-value |
Number of eyes (%) | 26 | 40 (43.4) | 26 (28.3) | 26 (28.3) | 92 | — |
Age, mean±SD, years | 66.3±11.2 | 60.6 (±13.5) | 69.2 (±8.8) | 58.3 (±14.1) | 61.6 (±13.4) | 0.141* |
Female/Male | 14/12 | 18/22 | 10/16 | 11/15 | 39/53 | 0.263** |
IOP, mean±SD, mm Hg | 12.7±1.5 | 20.0 (±9.2) | 23.2 (±12.7) | 25.3 (±12.7) | 22.0 (±11.1) | <0.001* |
BCVA, mean±SD, logMAR | 0.56±0.43 | 0.41±0.3 | 0.52±0.41 | 1.61±0.78 | 0.48±0.41 | 0.043 |
No. of glaucoma medication, mean±SD | — | 1.5±1.3 | 1.1±1.2 | 2.1±1.7 | 1.5±1.3 | — |
Mean deviation, mean±SD, dB | −0.12±0.3 | −3.8±3.2 | −2.3±2.1 | −6.6±6.8 | −4.8±5.0 | <0.001* |
Aqueous level of EPO, mean±SEM mIU/ml | 0.8±0.51 | 18.4±4.5 | 17.5±7.9 | 134.9±22.1 | 56.7±9.3 | <0.001* |